SchwartzDLellouchJ.Explanatory and pragmatic attitudes in therapeutic trials. J Chronic Dis1967;
20: 637–648.
2.
ThorpeKEZwarensteinMOxmanADTreweekSFurbergCAltmanDG, et al.
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ2009;
180: E47–E57.
US Congress Office of Technology Assessment. Assessing the efficacy and safety of medical technologies.
Washington, DC:
US Government Printing Office; 1978.
7.
HaynesRBSackettDLGuyattGH, et al. Clinical epidemiology: how to do clinical practice research. 3rd edition.
Philadelphia, PA:
Lippincott Williams & Wilkins, 2006.
8.
KaranicolasPJMontoriVMDevereauxPJSchünemannHGuyattGH.A new 'mechanistic-practical’ framework for designing and interpreting randomized trials. J Clin Epidemiol2009;
62: 479–484.
SchneidermanMA. Therapeutic trials in cancer. Working paper prepared for WHO Expert Committee on Cancer Treatment, Geneva, Switzerland, 9–15 March 1965. WHO/CANC/66.66, 1966.
11.
ZwarensteinM. ‘Pragmatic’ and ‘explanatory’ attitudes to randomized trials. JLL Bulletin: commentaries on the history of treatment evaluation. 2016. See www.jameslindlibrary.org/articles/pragmatic-and-explanatory-attitudes-to-randomized-trials/ (last checked 4 October 2023). Also as Zwarenstein M.
‘Pragmatic’ and ‘explanatory’ attitudes to randomised trials. J R Soc Med2017;
110: 208–218.
12.
ChalmersIGlasziouP.Avoidable waste in the production and reporting of research evidence. Lancet2009;
374: 86–89.
13.
LoudonKTreweekSSullivanFDonnanPThorpeKEZwarensteinM.The PRECIS-2 tool: designing trials that are fit for purpose. BMJ2015;
350: h2147.
14.
PalakshappaJAGibbsKWLannanMTCranfordARTaylorSP.Systematic review of the “pragmatism” of pragmatic critical care trials. Crit Care Explor2022;
4: e0738.
15.
TaljaardMNichollsSGHowieAHNixHPCarrollKMoonPM, et al.
An analysis of published trials found that current use of pragmatic trial labels is uninformative. J Clin Epidemiol2022;
151: 113–121.
16.
ArmitageP.Attitudes in clinical trials. Stat Med1998;
17: 2675–2683.
17.
SchwartzDFlamantRLellouchJ.Clinical Trials. Translated by MJR Healy.
London:
Academic Press, 1980.
18.
KoukourakisG.Which is the best neoadjuvant (pre-surgery) chemoradiation regimen for locally advanced rectal carcinoma? Short or long course of radiation therapy? Do we have new data?J BUON2020;
25: 51–61.
19.
McIsaacDIGillMBolandLHuttonBBranjeKShawJ, et al.; Prehabilitation Knowledge Network.
Prehabilitation in adult patients undergoing surgery: an umbrella review of systematic reviews. Br J Anaesth2022;
128: 244–257.
20.
RazRElchanan GColodnerRReissSSchvartzmanPTabenkinHLeshemY.
Penicillin V twice daily vs. four times daily in the treatment of streptococcal pharyngitis. Infect Dis Clin Practice1995;
4: 50–54.
21.
FIELD Study Investigators.
The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study [ISRCTN64783481]. Cardiovasc Diabetol2004;
3: 9.
22.
MacMahonSSharpeNGambleGHartHScottJSimesJ, et al.
Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation1998;
97: 1784–1790.
23.
VoyseyMClemensSACMadhiSAWeckxLYFolegattiPMAleyPK, et al.; Oxford COVID Vaccine Trial Group.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet2021;
397: 99–111.
